Hodgkin Lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential Diagnosis

  • Yamauchi Hirofumi
    Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan
  • Momoki Mamiko
    Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan
  • Kamiyama Yutaro
    Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan
  • Gunji Tadahiro
    Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan
  • Yokoyama Hiroki
    Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan
  • Saito Takeshi
    Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan
  • Boutboul David
    Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP), France
  • Oksenhendler Eric
    Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris (APHP), France
  • Yano Shingo
    Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan

抄録

<p>Hodgkin lymphoma (HL) and idiopathic multicentric Castleman disease (iMCD) are markedly different conditions. However, in some cases, histological similarities caused by elevated cytokines, including interleukin-6, can lead to a misdiagnosis of HL as Castleman disease (CD). We herein report a patient with HL who had been diagnosed with CD by an expert panel and for whom an additional biopsy was useful for determining the correct diagnosis. Furthermore, we analyzed the positron emission tomography/computed tomography findings at the diagnosis and found that the maximum standardized uptake value was useful for distinguishing HL from iMCD. </p>

収録刊行物

  • Internal Medicine

    Internal Medicine 63 (7), 993-998, 2024-04-01

    一般社団法人 日本内科学会

参考文献 (16)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ